{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Planar+scintigraphy+scan&page=2", "query": { "intervention": "Planar scintigraphy scan", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Planar+scintigraphy+scan&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T20:37:35.114Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06080932", "title": "Ketogenic Intervention in Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression", "Ketosis" ], "interventions": [ { "name": "Ketogenic Diet", "type": "OTHER" }, { "name": "NIH Toolbox", "type": "OTHER" }, { "name": "gradCPT", "type": "OTHER" }, { "name": "Resting-state fMRI", "type": "OTHER" }, { "name": "Task-fMRI", "type": "OTHER" }, { "name": "CGM/CKM", "type": "OTHER" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Sleep Monitoring", "type": "OTHER" }, { "name": "Ketone/Glucose Monitoring", "type": "BIOLOGICAL" }, { "name": "Body Composition", "type": "OTHER" }, { "name": "PHQ-9", "type": "BEHAVIORAL" }, { "name": "WHO-5", "type": "BEHAVIORAL" }, { "name": "SKID", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL", "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 30, "start_date": "2023-02-20", "completion_date": "2024-12-21", "has_results": false, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06080932" }, { "nct_id": "NCT05239533", "title": "Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clear Cell Renal Cell Carcinoma", "Kidney Cancer", "Advanced Renal Cell Carcinoma" ], "interventions": [ { "name": "177Lu-labeled-girentuximab", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "89Zr-girentuximab PET/CT", "type": "DIAGNOSTIC_TEST" }, { "name": "177Lu whole body (WB) planar and SPECT/CT scans", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2022-02-16", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05239533" }, { "nct_id": "NCT01490723", "title": "Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Lymphoma" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "111In Ibritumomab", "type": "DRUG" }, { "name": "Planar Scintigraphy Imaging", "type": "PROCEDURE" }, { "name": "90Y IbritumomabTiuxetan", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Bendamustine", "type": "DRUG" }, { "name": "Thymoglobulin", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Mycophenolate", "type": "DRUG" }, { "name": "G-CSF", "type": "DRUG" }, { "name": "Stem Cell Transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 20, "start_date": "2013-01", "completion_date": "2019-04-24", "has_results": true, "last_update_posted_date": "2020-05-05", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01490723" }, { "nct_id": "NCT07840521", "title": "Investigating Near-Threshold Perception During Ultrasonic Deep Brain Stimulation", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Consciousness, Level Altered" ], "interventions": [ { "name": "Low-intensity focused ultrasound pulsation (LIFUP)", "type": "DEVICE" }, { "name": "Functional Magnetic Resonance Imaging (fMRI)", "type": "DEVICE" }, { "name": "Magnetic Resonance Spectroscopy", "type": "DEVICE" }, { "name": "Multi-modal glymphatic function MRI", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 90, "start_date": "2026-10", "completion_date": "2032-03", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07840521" }, { "nct_id": "NCT01879657", "title": "68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neuroendocrine Carcinoma" ], "interventions": [ { "name": "68Ga-DOTATATE", "type": "DRUG" }, { "name": "PET/CT", "type": "DIAGNOSTIC_TEST" }, { "name": "111In-pentetreotide OctreoScan", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Radio Isotope Therapy of America", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 169, "start_date": "2013-03-01", "completion_date": "2017-12-05", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01879657" }, { "nct_id": "NCT01453127", "title": "DaTSCAN Imaging in Aging and Neurodegenerative Disease", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dementia", "Parkinsonism", "Mild Cognitive Impairment", "REM Sleep Behavior Disorder" ], "interventions": [ { "name": "I-123 Ioflupane solution injection prior to SPECT scan (DaTscan)", "type": "DRUG" }, { "name": "Single photon emission computed tomography (SPECT) scan", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "40 Years to 90 Years" }, "enrollment_count": 500, "start_date": "2011-10", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01453127" }, { "nct_id": "NCT01237405", "title": "A Study of FolateScan in Patients With Knee Osteoarthritis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "99mTc-EC20", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Virginia Kraus", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2010-10", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2012-11-27", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01237405" }, { "nct_id": "NCT00316797", "title": "Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neurodegenerative Diseases" ], "interventions": [ { "name": "123-I INER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Institute for Neurodegenerative Disorders", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 35, "start_date": "2006-04", "completion_date": "2014-01", "has_results": false, "last_update_posted_date": "2014-04-10", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00316797" }, { "nct_id": "NCT02615067", "title": "Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "99mTc-MIP-1404 Injection", "type": "DRUG" }, { "name": "Whole-Body Planar and pelvic SPECT/CT scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Molecular Insight Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 531, "start_date": "2015-12", "completion_date": "2017-12-28", "has_results": false, "last_update_posted_date": "2019-04-10", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 33, "location_summary": "Duarte, California • Los Angeles, California • San Francisco, California + 26 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02615067" }, { "nct_id": "NCT05951816", "title": "A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Systemic Amyloidosis" ], "interventions": [ { "name": "99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.", "type": "DRUG" }, { "name": "99mTc-Pyrophosphate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 31, "start_date": "2023-09-18", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-28T20:37:35.114Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05951816" } ] }